Top of the Street: GSK, Campari, Bridgepoint Group
BUZZ-Top of the Street: GSK, Campari, Bridgepoint Group A round-up of notable broker activity this morning from Europe's top-ranked* analysts:
** Jefferies cuts British drugmaker GSK GSK.L to "hold" from "buy," citing weaker earnings momentum, launch execution risks and fewer key pipeline catalysts
** Equita cuts Italian spirits group Campari CPRI.MI to "hold" from "buy", citing a tougher US context and a need for more visibility on portfolio stabilization
** BofA raises British private equity group Bridgepoint Group BPTB.L to "buy" from "neutral," citing undervalued shares and stronger earnings growth prospects
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)
(Reporting by Amir Orusov and Marta Maciag)